Clinical Trial Update: Study of Nimotuzumab to Treat Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating nimotuzumab for colorectal cancer; the current status is reported as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Peking University | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: UNKNOWN